(Q45207632)

10 December 2017

title

Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages (English)

1 reference

10 December 2017

10

1 reference

10 December 2017

Gerhard Krönke

11

0 references

Simon Jones

object named as

Simon Jones

14

0 references

Stefan Rose-John

object named as

Stefan Rose-John

15

0 references

Georg Schett

17

object named as

Georg Schett

1 reference

10 December 2017

Christian Beyer

1

1 reference

10 December 2017

Jingang Huang

2

1 reference

10 December 2017

Jürgen Beer

3

1 reference

10 December 2017

Yun Zhang

4

1 reference

10 December 2017

Katrin Palumbo-Zerr

5

1 reference

10 December 2017

Pawel Zerr

6

1 reference

10 December 2017

Alfiya Distler

7

1 reference

10 December 2017

Clara Dees

8

1 reference

10 December 2017

Christiane Maier

9

1 reference

10 December 2017

Stefan Uderhardt

12

1 reference

10 December 2017

Oliver Distler

13

1 reference

10 December 2017

Tamas Oravecz

16

1 reference

10 December 2017

Jörg H W Distler

18

1 reference

10 December 2017

language of work or name

English

0 references

publication date

11 March 2014

1 reference

Annals of the Rheumatic Diseases

10 December 2017

published in

1 reference

10 December 2017

volume

74

1 reference

10 December 2017

issue

6

1 reference

10 December 2017

page(s)

1317-1324

1 reference

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Innovative antifibrotic therapies in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Systemic sclerosis: a prototypic multisystem fibrotic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Liver X receptor (LXR) regulates human adipocyte lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Simultaneous activation of the liver X receptors (LXR and LXR ) drives murine collagen-induced arthritis disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Liver x receptors in atherosclerosis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Activation of liver X receptors suppresses inflammatory gene expressions and transcriptional corepressor clearance in rheumatoid arthritis fibroblast like synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Integration of metabolism and inflammation by lipid-activated nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Liver X receptor biology and pharmacology: new pathways, challenges and opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Platelet-derived serotonin links vascular disease and tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Activation of pregnane X receptor inhibits experimental dermal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Overlapping gene expression profiles indicative of antigen processing and the interferon pathway characterize inflammatory fibrotic skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Animal models of systemic sclerosis: prospects and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Activation of LXRs prevents bile acid toxicity and cholestasis in female mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

The cytokine language of monocytes and macrophages in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

An update on an immune system that goes awry in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Macrophage biology in development, homeostasis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Immunopathogenesis of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Interleukin-6, its role in fibrosing conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Relationship between interleukin-6 and cardiac involvement in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

Molecular subsets in the gene expression signatures of scleroderma skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-204401

10.1136/ANNRHEUMDIS-2013-204401

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference